Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Talkspace, Inc. has entered into an Agreement and Plan of Merger with Universal Health Services, Inc. and UHS Merger Subsidiary, Inc. If the merger agreement is adopted and the merger is consummated, Merger Sub will merge with and into Talkspace, with Talkspace surviving as an indirect wholly owned subsidiary of UHS.
Under the terms, Talkspace common shareholders will receive $5.25 per share in cash, without interest, subject to withholding taxes and any required appraisal-rights exclusions. The special meeting of stockholders will be completely virtual, and the proxy materials reference a special meeting date to be set.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026